Description
Noromby is a formulation of enoxaparin, which is used to treat and prevent blood clots. It is typically prescribed to people with a diagnosis of atrial fibrillation, pulmonary embolism, or deep vein thrombosis.
Directions
Noromby is available in the following sizes:
- 20 mg
- 30 mg
- 40 mg
- 60 mg
- 100 mg
The dosage is based on factors like weight and kidney function. Take it exactly as prescribed by your doctor.
Ingredients
The active ingredient in Noromby is enoxaparin.
Interactions
Common drug-drug interactions with Noromby can include
- Acalabrutinib
- Alemtuzumab
- Aliskiren
- Anacaulase
- Anagrelide
- Angiotensin II Receptor Blockers
- Angiotensin-Converting Enzyme Inhibitors
- Antiplatelets
- Antithrombin
- Apixaban
- Bromperidol
- Caplacizumab
- Collagenase (Systemic)
- Dabigatran Etexilate
- Dasatinib
- Deferasirox
- Defibrotide
- Deoxycholic Acid
- Desirudin
- Dipyridamole
- Edoxaban
- Eplerenone
- Factor X (Human)
- Hemin
- Herbal Products with Anticoagulant/Antiplatelet Effects
- Ibritumomab Tiuxetan
- Ibrutinib
- Icosapent Ethyl
- Inotersen
- Kanamycin
- Lecanemab
- Limaprost
- Lipid Emulsion (Fish Oil Based)
- Mesoglycan
- MiFEPRIStone
- Nintedanib
- Nonsteroidal Anti-Inflammatory Agents
- Obinutuzumab
- Omacetaxine
- Omega-3 Fatty Acids
- Palifermin
- Pentosan Polysulfate Sodium
- Pentoxifylline
- Pirtobrutinib
- Potassium Salts
- Potassium-Sparing Diuretics
- Prostacyclin Analogues
- Protein C Concentrate (Human)
- Rivaroxaban
- Salicylates
- Sugammadex
- Sulodexide
- Thrombolytic Agents
- Tibolone
- Tipranavir
- Urokinase
- Vitamin K Antagonists (e.g., warfarin)
- Vorapaxar
- Warfarin
Cautions
Do not use this product if you have a history of heparin-induced thrombocytopenia (HIT).
Tell your doctor and pharmacist about all the drugs you take before starting this Noromby.
Side Effects
Adverse reactions with Noromby include:
- Acute posthemorrhagic anemia
- Alopecia
- Anaphylactic shock
- Anaphylaxis
- Angioedema
- Atrial fibrillation
- Bleeding at the injection site
- Bruising at the injection site
- Cardiac failure
- Confusion
- Dermatologic: Ecchymoses
- Drug reaction with eosinophilia and systemic symptoms
- Epidural intracranial hemorrhage
- Erythema at the injection site
- Fever
- Hematoma at the injection site
- Hematuria
- Hemorrhage
- Hepatotoxicity
- Hyperkalemia
- Hyperlipidemia
- Hypertriglyceridemia
- Hypersensitivity angiitis
- Increased serum alanine aminotransferase
- Increased serum aspartate aminotransferase
- Injection site reaction
- Irritation at the injection site
- Maculopapular rash
- Major hemorrhage
- Nausea
- Peripheral edema
- Pneumonia
- Pruritus
- Pulmonary edema
- Purpuric disease
- Retinal detachment
- Skin necrosis
- Thrombocythemia
- Thrombocytopenia
- Thrombosis
- Urticaria
- Vesiculobullous rash
References
Noromby [package insert]. Mississauga, Ontario: Juno Pharmaceuticals; October 2020.
About Dr. Conor Sheehy (Page Author)
Dr. Sheehy (BSc Molecular Biology, PharmD) works a clinical pharmacist specializing in cardiology, oncology, and ambulatory care. He’s a board-certified pharmacotherapy specialist (BCPS), and his experience working one-on-one with patients to fine tune their medication and therapy plans for optimal results makes him a valuable subject matter expert for our pharmacy. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 14413